ISCHEMIA CKD: No Difference In Outcomes Between Medical and Invasive Approaches to Ischemia in Patients with End Stage Renal Disease
The results of the International Study of Comparative Health Effectiveness with Medical…
DAPA-HF: Dapagliflozin Improves Heart Failure Outcomes in Patients With HFrEF Regardless of Diabetic Status
Dr. John McMurray presented the results of the DAPA-HF trial at the…
BETonMACE: Trial Shows Novel BET Protein Inhibitor Apabetalone Is Safe and Could Potentially Be Used To Improve Cardiovascular Outcomes
During the American Heart Association 2019 meeting, Dr. Kosh Ray presented the…
Phase 1 Trial Shows RUC-4 (A Novel Subcutaneous GPIIb/IIIa Inhibitor) Achieves Safe, Rapid and Effective Platelet Inhibition
The results of a phase 1 trial that evaluated the safety of…
ISCHEMIA: No Reduction in Cardiovascular Event in Patients with Stable Coronary Artery Disease Who Undergo Invasive Therapy
The results of the ISCHEMIA trial were presented by Dr. Judith Hochman…
COLCOT: Colchicine Reduced Cardiovascular Events in Patients with Recent Myocardial Infarction
The results of the COLCOT trial were presented by Dr. Jean-Claude Tardif…
Registry Data Demonstrates No Difference in Survival Between Extracorporeal CPR and Conventional CPR in Patients With Out of Hospital Cardiac Arrest
A study led by Dr. Wulfran Bougouin published in the European Heart…
20-Year Study Shows Statin Use Associated with Reduced Cardiovascular Event Rate in Children with Familial Hypercholesterolemia
A study led by Dr. Ilse Luirink published in the New England…
THEMIS Study: Ticagrelor Plus Aspirin Associated with Lower Ischemic Event Rate but Higher Bleeding Rate Than Aspirin Alone in Patients with Diabetes and Stable Coronary Artery Disease
Use of ticagrelor plus aspirin in patients with stable coronary artery disease…
17 Year Study Shows Changes in Income Can Influence the Occurrence of Cardiovascular Disease
A study led by Mr. Stephen Wang, published in JAMA Cardiology, showed…
ORION-1: 1-Year Follow-Up Data Affirms 2-dose Regimen Using 300 mg of Inclisiran For Persistent LDL-C Lowering
A randomized, double blind, placebo-controlled, phase II clinical trial studying the effect…
The COMPLETE Timing Substudy: A Randomized Trial of Complete Staged Revascularization Vs. Infarct Artery PCI Alone in Patients With Acute Myocardial Infarction and Multivessel Disease – Importance of Revascularization Timing
The results of a substudy of the COMPLETE Trial were presented at…
TWILIGHT Trial: Single Anti-Platelet Therapy (SAPT) Using Ticagrelor Reduces Bleeding Risk And Preserves Ischemia Prevention Post-PCI
A randomized, double-blinded, placebo-controlled trial which enrolled 7119 high risk patients with…
Dual Anti-thrombotic Therapy Safe For Patients with Atrial Fibrillation and Recent PCI:ENTRUST-AF PCI
Results from a phase-IIIb, open-label, multi-center, randomized clinical trial comparing the safety…
PolyIran Trial: Polypill Prevents Cardiovascular Events
A four-component polypill, including aspirin, atorvastatin, hydrochlorothiazide, and enalapril or valsartan, effectively…
CLIMA Registry: OCT-Defined Plaque Morphology Links to Major Coronary Events
Data from CLIMA registry shows that simultaneous presence of four optical coherence…
Novel Physiology-Based Method of Estimating Myocardial Ischemic Burden
Murai et al. devised a novel physiology-based method of estimating the amount…
Fractional Flow Reserve Aids Decision Making for Intermediate Coronary Lesions: 1-Month Data from FORZA Study
Compared with optical coherence tomography (OCT), fractional flow reserve (FFR) was associated…
IMPROVE-IT Trial: Intensive Lipid-Lowering Cuts CVD Risk in the Elderly
Among patients hospitalized for an acute coronary syndrome (ACS), adding ezetimibe to…
Study Suggests Increased Risk of Coronary Artery Disease in Black Women With Complications During Pregnancy
A study led by Dr. Julian Wichmann published in JACC: Cardiovascular Imaging…